PU-SC
Home » Products » Air Fittings » New Product 304 Stainless Steel Air Fittings » PU-SC

Product Category

Contact us

loading

Share to:
facebook sharing button
twitter sharing button
linkedin sharing button
pinterest sharing button
sharethis sharing button

SS-31 10MG 50MG

SKU:
Availability:

SS-31, also known as Bendavia or elamipretide, is a synthetic peptide designed to target and protect mitochondria, the powerhouse of the cell. Developed by Stealth BioTherapeutics, SS-31 emerged from research aimed at addressing mitochondrial dysfunction, a hallmark of various age-related diseases and pathological conditions. Originally investigated for its potential in cardiovascular disorders, SS-31 has since garnered interest for its broader therapeutic applications in neurodegenerative diseases, metabolic disorders, and ischemia-reperfusion injury.


How it Works: SS-31 exerts its effects by selectively targeting the inner mitochondrial membrane, where it interacts with cardiolipin, a phospholipid essential for mitochondrial function and stability. By binding to cardiolipin, SS-31 stabilizes mitochondrial membranes, reduces oxidative stress, and preserves mitochondrial integrity. Additionally, SS-31 facilitates ATP production, enhances cellular respiration, and mitigates apoptosis, thereby promoting overall mitochondrial health and function.


Benefits to the Body: The therapeutic benefits of SS-31 extend to various physiological systems, owing to its ability to protect and preserve mitochondrial function. Preclinical studies have demonstrated its efficacy in reducing oxidative damage, attenuating inflammation, and improving tissue viability in conditions characterized by mitochondrial dysfunction. Moreover, SS-31 has shown promise in mitigating age-related decline in cognitive function, enhancing exercise performance, and promoting cardiovascular health.


Potential Risks: While SS-31 appears to be well-tolerated and devoid of significant adverse effects in preclinical studies and early clinical trials, its safety profile in humans requires further elucidation. Potential risks, including allergic reactions, immunogenicity, and off-target effects, should be considered, particularly in individuals with pre-existing medical conditions or compromised mitochondrial function. Long-term studies are needed to assess the safety and tolerability of SS-31 supplementation in diverse patient populations.


Recommended Dosage: The recommended dosage of SS-31 can vary depending on the specific condition being treated, the severity of mitochondrial dysfunction, and individual response. While there is no standardized dosage established, typical regimens range from 0.5 to 10 milligrams (mg) per day, administered via intravenous infusion or subcutaneous injection. Treatment duration may vary depending on the extent of mitochondrial dysfunction and the desired therapeutic outcomes, with periodic reassessment of clinical parameters.



SS-31, also known as Bendavia or elamipretide, is a synthetic peptide designed to target and protect mitochondria, the powerhouse of the cell. Developed by Stealth BioTherapeutics, SS-31 emerged from research aimed at addressing mitochondrial dysfunction, a hallmark of various age-related diseases and pathological conditions. Originally investigated for its potential in cardiovascular disorders, SS-31 has since garnered interest for its broader therapeutic applications in neurodegenerative diseases, metabolic disorders, and ischemia-reperfusion injury.


How it Works: SS-31 exerts its effects by selectively targeting the inner mitochondrial membrane, where it interacts with cardiolipin, a phospholipid essential for mitochondrial function and stability. By binding to cardiolipin, SS-31 stabilizes mitochondrial membranes, reduces oxidative stress, and preserves mitochondrial integrity. Additionally, SS-31 facilitates ATP production, enhances cellular respiration, and mitigates apoptosis, thereby promoting overall mitochondrial health and function.


Benefits to the Body: The therapeutic benefits of SS-31 extend to various physiological systems, owing to its ability to protect and preserve mitochondrial function. Preclinical studies have demonstrated its efficacy in reducing oxidative damage, attenuating inflammation, and improving tissue viability in conditions characterized by mitochondrial dysfunction. Moreover, SS-31 has shown promise in mitigating age-related decline in cognitive function, enhancing exercise performance, and promoting cardiovascular health.


Potential Risks: While SS-31 appears to be well-tolerated and devoid of significant adverse effects in preclinical studies and early clinical trials, its safety profile in humans requires further elucidation. Potential risks, including allergic reactions, immunogenicity, and off-target effects, should be considered, particularly in individuals with pre-existing medical conditions or compromised mitochondrial function. Long-term studies are needed to assess the safety and tolerability of SS-31 supplementation in diverse patient populations.


Recommended Dosage: The recommended dosage of SS-31 can vary depending on the specific condition being treated, the severity of mitochondrial dysfunction, and individual response. While there is no standardized dosage established, typical regimens range from 0.5 to 10 milligrams (mg) per day, administered via intravenous infusion or subcutaneous injection. Treatment duration may vary depending on the extent of mitochondrial dysfunction and the desired therapeutic outcomes, with periodic reassessment of clinical parameters.



Previous:  SNAP-8 10MG
Next:  Thymalin 10MG
YIWU AOZUO enterprise engaged in beauty peptides products,For more details,please contact us:lisa.yan@aozuotrade.com

Quick links

Products

Get In Touch

   +86 177 0331 5367
   +86 177 0331 5367
  NO.202,Yinhai District 3,Futian Road,Yiwu City,Zhejiang Province,China
Copyright  Yiwu Aozuo Trading Firm